A New Era in HER2-Positive Breast Cancer Therapy (IMAGE)

Korea University College of Medicine

A New Era in HER2-Positive Breast Cancer Therapy

Caption

HVH-2930 selectively inhibits HSP90, leading to the downregulation of HER2 signaling, a key pathway implicated in breast cancer progression.

Credit

Professor Jae Hong Seo from Korea University

Usage Restrictions

Cannot be reused without permission

License

Original content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.